Status:
UNKNOWN
Telerehabilitation Alzheimer's Disease Feasibility (TADF)
Lead Sponsor:
Bright Cloud International Corp
Collaborating Sponsors:
National Institute on Aging (NIA)
Rutgers, The State University of New Jersey
Conditions:
Alzheimer Disease
Healthy Aging
Eligibility:
All Genders
65-85 years
Phase:
NA
Brief Summary
This is a pilot RCT with equal arms: experimental arm and (wait list) control arm. All participants will be in the early stage of Alzheimer's disease and on stable medication. They will all continue ...
Detailed Description
Participants will be randomized equally into an experimental group and a wait list control group. Experimental training will occur in the home, and will last 8 weeks, each week having 5 sessions of t...
Eligibility Criteria
Inclusion
- Age 65 to 85;
- Diagnosis of early Alzheimer's (Montreal Cognitive Assessment \[MoCA\] score of 19-25) \[Nasreddine et al 2005\].
- English speakers;
- Ability to actively move UE and to flex/extend fingers;
- Stable on Aricept 10 mg daily intake or Exelon 9.5 mg patch medication
- Able to consent;
- Living in the community in Central Jersey so to facilitate researchers travel to home for system installation and/or repairs,
- Living with a caregiver willing to support trials and be present during sessions;
- Good upper extremity motor function, close to full range of movement of arms and fingers.
Exclusion
- Those younger than 65;
- Participating in other research studies;
- Severe visual impairments or legally blind;
- Severe hearing loss or deafness;
- Uncontrolled hypertension (\>190/100 mmHg);
- Severe cognitive delay (MoCA \<19);
- non-English speakers;
- Those unable to provide consent;
- Unable to move arms and fingers, or with severe arthritis;
- Severe propensity to simulation sickness;
- Those who are not cooperative with the evaluations pre-study ;
- Those who cannot produce reliable scores on the neuropsychological pre-study assessment because they do not comprehend the test, or have severe speech impairment;
- Those not living with a caregiver willing to support trials, and caregiver unwilling or unable to be present during sessions;
- Those that are unwilling allow home inspections to ascertain internet conditions in the home, to determine best placement for the experimental system, to install and remove system, and to provide repairs if needed.
Key Trial Info
Start Date :
February 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2023
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04732182
Start Date
February 16 2022
End Date
February 28 2023
Last Update
May 2 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers, The State University of New Jersey
New Brunswick, New Jersey, United States, 08901-2066
2
Bright Cloud Int'l Corp
North Brunswick, New Jersey, United States, 08902